Suchergebnisse - "Subramanian, Sreedhar"

PubPharm (137)

11

IBD Risk-It Is All in the Family!

enthalten in: Journal of Crohn's & colitis | 2023

von Sharip, M. | Subramanian, S.

12

Genome-Wide Methylation Profiling in 229 Patients With Crohn's Disease Requiring Intestinal Resection : Epigenetic Analysis of the Trial of Prevention of Post-operative Crohn's Disease (TOPPIC)

enthalten in: Cellular and molecular gastroenterology and hepatology | 2023

von Ventham, N. | Kennedy, N. | Kalla, R. | +103

13

Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn’s Disease Patients

enthalten in: Digestive diseases and sciences | 2022

von Gebeyehu, G. | Fiske, J. | Liu, E. | +7

14

Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn’s Disease Patients

enthalten in: Digestive diseases and sciences | 2022

von Gebeyehu, G. | Fiske, J. | Liu, E. | +7

15

Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn’s Disease Patients

enthalten in: Digestive diseases and sciences | 2022

von Gebeyehu, G. | Fiske, J. | Liu, E. | +7

16

Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic : the PREPARE-IBD multicentre cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Saifuddin, A. | Kent, A. | Mehta, S. | +113

CommentIn: Aliment Pharmacol Ther. 2023 Jan;57(1):156-157. - PMID 36468219

17

Safety and effectiveness of ustekinumab in elderly Crohn's disease patients

enthalten in: European journal of gastroenterology & hepatology | 2022

von Fiske, J. | Liu, E. | Limdi, J. | +12

18

Vitamin D and COVID-19-Revisited

enthalten in: Journal of internal medicine | 2022

von Subramanian, S. | Griffin, G. | Hewison, M. | +6

19

Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13] : A Multicentre Cohort Study

enthalten in: Journal of Crohn's & colitis | 2022

von Smith, P. | Critchley, L. | Storey, D. | +17

20

Editorial : intravenous to subcutaneous vedolizumab-switch without glitch!

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Nadesalingam, V. | Subramanian, S.

CommentOn: Aliment Pharmacol Ther. 2022 Jun;55(11):1389-1401. - PMID 35470449